News - ExCellThera

March 27, 2024

ExCellThera announces a presentation on advances in stem cell expansion by its Chief Scientific Officer at the EBMT 2024 Annual Meeting

– Dr. Guy Sauvageau, Chief Scientific Officer at ExCellThera will present on current indications and prospects of hematopoietic stem cell expansion at the EBMT 2024 Annual Meeting. MONTREAL, March 27, 2024 – ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and metabolic fitness, announced today that Dr. Guy Sauvageau, the company’s Chief […]

ExCellThera Announces Publication in Blood Highlighting the Potential for UM171 to Result in Efficient Stem Cell Expansion for Therapeutic Use

– Data expand on previously described mechanism of action and validate use of UM171 to create improved hematopoietic stem cell (HSC) therapies, including UM171 Cell Therapy – Company expects to initiate a Phase 3 study for UM171 Cell Therapy for the treatment of high and very high-risk acute leukemias and myelodysplasias in 2024 MONTREAL, February […]

ExCellThera to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference and to Participate in Upcoming Investor Conferences

MONTREAL, January 2, 2024 – ExCellThera Inc. (ExCellThera), a world leader in blood stem cell therapies, announced today that its senior leaders will be holding investor meetings during the 42nd Annual J.P. Morgan Healthcare Conference, January 8-11, 2024, in San Francisco, CA, and will be participating in the following investor conferences in January: 2024 Biotech […]